<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ANP</journal-id>
<journal-id journal-id-type="hwp">spanp</journal-id>
<journal-title>Australian and New Zealand Journal of Psychiatry</journal-title>
<issn pub-type="ppub">0004-8674</issn>
<issn pub-type="epub">1440-1614</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0004867411430878</article-id>
<article-id pub-id-type="publisher-id">10.1177_0004867411430878</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
<subj-group subj-group-type="heading">
<subject>Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The contribution of BDNF and 5-HTT polymorphisms and early life stress to the heterogeneity of major depressive disorder: A preliminary study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Quinn</surname><given-names>Candice R</given-names></name>
<xref ref-type="aff" rid="aff1-0004867411430878">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Dobson-Stone</surname><given-names>Carol</given-names></name>
<xref ref-type="aff" rid="aff2-0004867411430878">2</xref>
<xref ref-type="aff" rid="aff3-0004867411430878">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Outhred</surname><given-names>Tim</given-names></name>
<xref ref-type="aff" rid="aff4-0004867411430878">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Harris</surname><given-names>Anthony</given-names></name>
<xref ref-type="aff" rid="aff1-0004867411430878">1</xref>
<xref ref-type="aff" rid="aff5-0004867411430878">5</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Kemp</surname><given-names>Andrew H</given-names></name>
<xref ref-type="aff" rid="aff4-0004867411430878">4</xref>
</contrib>
</contrib-group>
<aff id="aff1-0004867411430878"><label>1</label>Discipline of Psychiatry, Sydney Medical School, University of Sydney, Sydney, Australia</aff>
<aff id="aff2-0004867411430878"><label>2</label>Neuroscience Research Australia, Sydney, Australia</aff>
<aff id="aff3-0004867411430878"><label>3</label>School of Medical Sciences, University of New South Wales, Sydney, Australia</aff>
<aff id="aff4-0004867411430878"><label>4</label>School of Psychology, University of Sydney, Sydney, Australia</aff>
<aff id="aff5-0004867411430878"><label>5</label>Brain Dynamics Centre and Westmead Millennium Institute, University of Sydney, Westmead Hospital, Sydney, Australia</aff>
<author-notes>
<corresp id="corresp1-0004867411430878">Andrew H Kemp, The School of Psychology, Brennan MacCallum Building (A18), University of Sydney, NSW 2006, Australia. Email: <email>andrew.kemp@sydney.edu.au</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>1</month>
<year>2012</year>
</pub-date>
<volume>46</volume>
<issue>1</issue>
<fpage>55</fpage>
<lpage>63</lpage>
<permissions>
<copyright-statement>© The Royal Australian and New Zealand College of Psychiatrists 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">The Royal Australian and New Zealand College of Psychiatrists</copyright-holder>
</permissions>
<abstract>
<p><bold>Objective:</bold> Two reported genetic polymorphisms related to the production of brain-derived neurotrophic factor (BNDF) and reuptake by the serotonin transporter (5-HTT) appear to contribute to depression in combination with stressful life events. The aim of the current study was to investigate the contribution of early life stress (ELS), BDNF (Val versus Met alleles) and 5-HTT polymorphisms (L versus S alleles) to melancholic (<italic>n</italic> = 65) and non-melancholic depression (<italic>n</italic> = 59).</p>
<p><bold>Methods:</bold> A mediation approach ((G × G) × E mediation model) was employed to confirm the indirect effects of ELS on the relationship between 5-HTTPLR × BDNF polymorphism combinations and depression subtype. A series of binary logistic regressions were then conducted to determine whether genotype, ELS, and their interaction were able to predict depression subtype.</p>
<p><bold>Results:</bold> Key findings indicated that BDNF and 5-HTT polymorphisms in combination with ELS contributed to the development of non-melancholic depression. An interaction between BDNF and ELS increased the risk of non-melancholia by 3.327, whereas the interaction between 5-HTT and ELS increased risk by 2.406.</p>
<p><bold>Conclusion:</bold> The results support a role for genetic factors in the development of non-melancholia. The lack of findings in melancholia indicates that other mechanisms may underlie the subtype. Alternatively, null findings may reflect a Type II error associated with a small sample size. Future studies should consider further examination of differential gene–environment interactions for melancholia versus non-melancholia.</p>
</abstract>
<kwd-group>
<kwd>Brain-derived neurotrophic factor</kwd>
<kwd>early life stress</kwd>
<kwd>genetics</kwd>
<kwd>melancholia</kwd>
<kwd>serotonin transporter gene</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0004867411430878" sec-type="intro">
<title>Introduction</title>
<p>Major depressive disorder (MDD) is a leading cause of morbidity affecting 120 million people worldwide (<xref ref-type="bibr" rid="bibr68-0004867411430878">World Health Organisation, 2005</xref>). The heritability rate of depression has been estimated as high as 70% (<xref ref-type="bibr" rid="bibr38-0004867411430878">Kendler et al., 1993</xref>), with current estimates proposing rates of between 30% and 40% (<xref ref-type="bibr" rid="bibr64-0004867411430878">Sullivan et al., 2000</xref>). The overall relative risk for a first-degree relative is two to three (<xref ref-type="bibr" rid="bibr64-0004867411430878">Sullivan et al., 2000</xref>), suggesting that genetics may play a significant role in the aetiology of the disorder. The most widely studied gene associated with depression is <italic>SLC6A4</italic>, which encodes the serotonin transporter (5-HTT) (<xref ref-type="bibr" rid="bibr42-0004867411430878">Levinson, 2009</xref>). The S allele leads to lower production of 5-HTT, which decreases the reuptake capacity for serotonin (<xref ref-type="bibr" rid="bibr41-0004867411430878">Lesch et al., 1996</xref>). Research on the epidemiology of depression indicates a role for a gene × environment interaction involving the S allele in combination with stressful life events (<xref ref-type="bibr" rid="bibr8-0004867411430878">Caspi et al., 2003</xref>; <xref ref-type="bibr" rid="bibr11-0004867411430878">Cervilla et al., 2007</xref>; <xref ref-type="bibr" rid="bibr32-0004867411430878">Jacobs et al., 2006</xref>; <xref ref-type="bibr" rid="bibr37-0004867411430878">Kendler et al., 2005</xref>; <xref ref-type="bibr" rid="bibr40-0004867411430878">Kim et al., 2007</xref>; <xref ref-type="bibr" rid="bibr67-0004867411430878">Wilhelm et al., 2006</xref>) and the presence of this S allele has also been associated with poor response to anti-depressant medication (see <xref ref-type="bibr" rid="bibr36-0004867411430878">Kemp et al., 2008</xref> for review). Other research implicates a role for the BDNF Val66Met polymorphism in depression (<xref ref-type="bibr" rid="bibr31-0004867411430878">Hwang et al., 2006</xref>; <xref ref-type="bibr" rid="bibr33-0004867411430878">Jiang et al. 2005</xref>). BDNF, a neuroprotective protein, acts in order to promote neurogenesis: the growth and differentiation of new neurons and synapses (<xref ref-type="bibr" rid="bibr1-0004867411430878">Acheson et al., 1995</xref>; <xref ref-type="bibr" rid="bibr30-0004867411430878">Huang and Reichardt, 2001</xref>). The BDNF Met allele is associated with inefficient BDNF secretion (<xref ref-type="bibr" rid="bibr18-0004867411430878">Egan et al., 2003</xref>) and BDNF is decreased in patients with depression (<xref ref-type="bibr" rid="bibr9-0004867411430878">Castren, 2004</xref>, <xref ref-type="bibr" rid="bibr10-0004867411430878">2005</xref>; <xref ref-type="bibr" rid="bibr12-0004867411430878">Chen et al., 2001</xref>; <xref ref-type="bibr" rid="bibr17-0004867411430878">Duman and Monteggia, 2006</xref>; <xref ref-type="bibr" rid="bibr34-0004867411430878">Karege et al., 2005</xref>; <xref ref-type="bibr" rid="bibr61-0004867411430878">Shimizu, 2003</xref>). In addition, Met heterozygotes have been reported to be more likely to ruminate, a core feature of depression, than individuals homozygous for the Val allele (<xref ref-type="bibr" rid="bibr3-0004867411430878">Beevers et al., 2009</xref>). Researchers have further suggested that alterations in serotonergic activity may reflect underlying plasticity changes subserved by BDNF (<xref ref-type="bibr" rid="bibr47-0004867411430878">Munafo et al., 2005</xref>; <xref ref-type="bibr" rid="bibr65-0004867411430878">Urani et al., 2005</xref>). Repeated exposure to early life stress (ELS) leads to neuronal loss in regions central for emotion and memory function such as the limbic system, hippocampus and amygdala (<xref ref-type="bibr" rid="bibr28-0004867411430878">Heim and Nemeroff, 1999</xref>). These locations are implicated in depression, and BDNF has been shown to directly impact plasticity and growth in these regions (<xref ref-type="bibr" rid="bibr5-0004867411430878">Black, 1999</xref>; <xref ref-type="bibr" rid="bibr15-0004867411430878">Conner et al., 1997</xref>; <xref ref-type="bibr" rid="bibr55-0004867411430878">Rattiner et al., 2004</xref>). However, not all studies have been able to replicate the association between these genetic polymorphisms and depression (<xref ref-type="bibr" rid="bibr13-0004867411430878">Chen et al., 2008</xref>; <xref ref-type="bibr" rid="bibr56-0004867411430878">Risch et al., 2009</xref>). While it is possible that these contradictory reports relate to underlying genetic heterogeneity, studies remain to be conducted that investigate this possibility. The current study aims to investigate the contribution of 5-HTT and BDNF genetic polymorphisms to subtypes of MDD.</p>
<p>Melancholic depression is a unique subtype of depression characterised by increased hyperarousal and hypercortisolaemia (<xref ref-type="bibr" rid="bibr22-0004867411430878">Gold and Chrousos, 2002</xref>) that can lead to neuronal atrophy in the hippocampus (<xref ref-type="bibr" rid="bibr4-0004867411430878">Belmaker and Agam, 2008</xref>). This effect can be resolved by antidepressant treatment (<xref ref-type="bibr" rid="bibr6-0004867411430878">Brunoni et al., 2008</xref>; <xref ref-type="bibr" rid="bibr59-0004867411430878">Santarelli et al., 2003</xref>). Antidepressants that modulate both serotonin and norepinephrine are more efficacious in patients with melancholia (<xref ref-type="bibr" rid="bibr44-0004867411430878">Malhi et al., 2005a</xref>), while non-melancholic patients respond well to antidepressants modulating only serotonin (<xref ref-type="bibr" rid="bibr48-0004867411430878">National Institute for Clinical Excellence, 2004</xref>). These findings have been reflected in structural and functional models of depression (<xref ref-type="bibr" rid="bibr45-0004867411430878">Malhi et al., 2005b</xref>), which support an association between subtypes of depression and neurotransmitter systems. Interestingly, the BDNF Met/Met genotype has been associated with impairments in emotion and cognition similar to those observed in depressed patients (<xref ref-type="bibr" rid="bibr27-0004867411430878">Hasler et al., 2004</xref>; <xref ref-type="bibr" rid="bibr46-0004867411430878">Mayberg, 1997</xref>) and those with melancholia in particular, including deficits in verbal memory (<xref ref-type="bibr" rid="bibr16-0004867411430878">Dempster et al., 2005</xref>; <xref ref-type="bibr" rid="bibr18-0004867411430878">Egan et al., 2003</xref>), visual memory (<xref ref-type="bibr" rid="bibr25-0004867411430878">Hariri et al., 2003</xref>), working memory and executive functioning (<xref ref-type="bibr" rid="bibr21-0004867411430878">Gatt et al., 2009</xref>; <xref ref-type="bibr" rid="bibr58-0004867411430878">Rybakowski et al., 2003</xref>). We have previously demonstrated that an interaction between the BDNF Met allele and exposure to ELS predicts neural circuitry and autonomic arousal pathways to depression and anxiety (<xref ref-type="bibr" rid="bibr21-0004867411430878">Gatt et al., 2009</xref>), and anxiety comorbidity is a common feature of melancholia (<xref ref-type="bibr" rid="bibr22-0004867411430878">Gold and Chrousos, 2002</xref>).</p>
<p>The current study examined the contribution of 5-HTT and BDNF genetic polymorphisms to melancholic and non-melancholic depression. On the basis of prior research, we hypothesise that patients with non-melancholia will be characterised by a combination of the 5-HTT S allele and an increased number of ELS events, while melancholia will be characterised by a combination of the 5-HTT S allele, BDNF Met allele and an increased number of ELS events. We further hypothesise that gene by environment interaction effects will predict depression subtype over and above main effects.</p>
</sec>
<sec id="section2-0004867411430878" sec-type="methods">
<title>Methods</title>
<sec id="section3-0004867411430878">
<title>Participants</title>
<p>A total of 128 participants with a primary diagnosis of MDD and 128 healthy control participants were recruited from the community in collaboration with the Brain Resource International Database (<xref ref-type="bibr" rid="bibr23-0004867411430878">Gordon et al., 2005</xref>). Exclusion criteria included a history of brain injury (causing loss of consciousness for 10 minutes or more), neurological disorder, psychiatric illness except for depression or a secondary diagnosis of anxiety, current substance dependence disorder or other serious medical condition. Depressed participants with co-morbid anxiety were included to maximise the generalisability of the sample. Secondary diagnoses included generalised anxiety disorder (<italic>n</italic> = 47), panic disorder (<italic>n</italic> = 29), and post-traumatic stress disorder (<italic>n</italic> = 14). All participants were medication free for at least five half-lives. All depressed participants met criteria for MDD as determined by research officers trained and supervised by collaborating psychiatrists using the Mini International Neuropsychological Interview (MINI: <xref ref-type="bibr" rid="bibr60-0004867411430878">Sheehan et al., 1998</xref>), a structured psychiatric interview based on the <italic>Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition</italic> (DSM-IV: <xref ref-type="bibr" rid="bibr2-0004867411430878">American Psychiatric Association, 2000</xref>). Severity of depression was measured using the Hamilton Rating Scale for Depression (HRSD: <xref ref-type="bibr" rid="bibr24-0004867411430878">Hamilton, 1960</xref>); melancholic features, using CORE Assessment of Psychomotor Change (CORE: <xref ref-type="bibr" rid="bibr51-0004867411430878">Parker et al., 1995</xref>; <xref ref-type="bibr" rid="bibr50-0004867411430878">Parker and Hadzi-Pavlovic, 1996</xref>); ELS, by the self-report Early Life Stress Questionnaire (ELSQ: <xref ref-type="bibr" rid="bibr14-0004867411430878">Cohen et al., 2006</xref>); and self-reports of depression, anxiety and stress, using the Depression, Anxiety and Stress Scales (DASS: <xref ref-type="bibr" rid="bibr43-0004867411430878">Lovibond and Lovibond, 1995</xref>). All participants gave written informed consent in accordance with Australian National Health and Medical Research Council (NHMRC) ethical guidelines.</p>
</sec>
<sec id="section4-0004867411430878">
<title>Procedure</title>
<p>After providing consent, trained research officers administered the MINI and HRSD, and completed the CORE. Patients were diagnosed as melancholic (MEL; <italic>n</italic> = 65) or non-melancholic (NMEL; <italic>n</italic> = 59) on the basis of the MINI. Participants then completed the DASS and ELSQ at the completion of the clinical interview.</p>
</sec>
<sec id="section5-0004867411430878">
<title>Genotyping</title>
<p>DNA was extracted from cheek swab samples. The 5-HTTPLR genotype was determined by size separation of polymerase chain reaction (PCR) products using a modification of a previously established method (<xref ref-type="bibr" rid="bibr19-0004867411430878">Gatt et al., 2007</xref>, <xref ref-type="bibr" rid="bibr20-0004867411430878">2008</xref>; <xref ref-type="bibr" rid="bibr67-0004867411430878">Wilhelm et al., 2006</xref>). PCR amplification of participant DNA was undertaken using primers 5’-TGCCGCTCTGAATGCCAGCAC-3’ and 5’-GCGG GATTCTGGTGCCACCTA-3’ in a reaction containing 400 mM betaine, 0.16 mM each of dATP, dCTP and dTTP, and 0.08 mM each of dGTP and 7-deaza-2’deoxyguanosine 5’-triphosphate. PCR amplification conditions were as follows: 94°C for 2 min; 35 cycles of 94°C for 30 s, 65°C for 45 s and 72°C for 90 s; 72°C for 10 min. PCR amplicons were separated by electophoresis on 2% agarose gels. BDNF Val66Met genotype was determined using PCR amplification and restriction digest. PCR amplification of participant DNA was undertaken using primers 5’-TGTATTCCTCCAGCAGAAAGAGAA-3’ and 5’-AA AGAAGCAAACATCCGAGGAC-3’ and standard conditions. Amplified fragments were digested with the restriction enzyme <italic>Afl</italic> III and digests were separated on 4% agarose gels. Genotypes were scored independently by two researchers.</p>
</sec>
<sec id="section6-0004867411430878">
<title>Statistical analyses</title>
<p>All statistical analyses were performed using SPSS (Version 17; SPSS Inc., Chicago, IL, USA). Initially, group characteristics were examined using one-way analyses of variance (i.e. 3 Group (MEL, NMEL, CTRL) × 2 Genotype (LL, SL or SS; VV, VM or MM) and follow-up post-hoc tests using Tukey’s HSD on total ELS events and chi square analyses on genotype. Next we conducted a mediation analysis ((G × G) × E mediation model) using the Preacher and Hayes method (<xref ref-type="bibr" rid="bibr54-0004867411430878">Preacher and Hayes, 2008</xref>) to confirm a mediating role of ELS in the relationship between 5-HTTPLR × BDNF polymorphism combinations and subtype (MEL, NMEL, CTRL), in which age and gender were entered as covariates. The <xref ref-type="bibr" rid="bibr54-0004867411430878">Preacher and Hayes (2008)</xref> SPSS Macro was configured for 5000 bootstrap samples and 95% confidence. Finally, we examined whether ELS, genotype and their interaction were able to predict depression subtype using a series of binary logistic regressions using the enter method such that all the variables were entered at the same time. Logistic regression was chosen above multinomial regression as values related to diagnosis are ordered and independent categories. Thus, using a binary model we were able to test each category independently. This method was chosen to test our primary hypothesis: an interaction between the predictors (e.g. <italic>y</italic> = <italic>b</italic><sub>0</sub> + <italic>b</italic><sub>1</sub>(<italic>A</italic>) …)(e.g. for <italic>A</italic> and <italic>B</italic> in <italic>y</italic> = <italic>b</italic><sub>0</sub> + <italic>b</italic><sub>1</sub>(<italic>A</italic>) + <italic>b</italic><sub>2</sub>(<italic>B</italic>) + <italic>b</italic><sub>3</sub>(<italic>A</italic>*<italic>B</italic>) + error) over and above the main effects (i.e. <italic>A</italic> and <italic>B</italic>). All main and interaction effects were therefore tested in the model. The regressions were completed with the following reference categories for dependent variables: 1. NMEL = 0, MEL = 1; 2. CTRL = 0; MEL = 1; and 3. CTRL = 0; NMEL = 1. Analyses focused on whether interaction effects were significant over and above main effects using the following regression equation: ln(odds (dependent variable)) = <italic>b</italic><sub>0</sub> + <italic>b</italic><sub>1</sub>(BDNF)<sub>1</sub> + <italic>b</italic><sub>2</sub>(5-HTT)<sub>2</sub> + <italic>b</italic><sub>3</sub>(ELS)<sub>3</sub> + <italic>b</italic><sub>4</sub>(BDNF × ELS)<sub>4</sub> + <italic>b</italic><sub>5</sub>(5-HTT × ELS)<sub>5</sub> + <italic>b</italic><sub>6</sub>(BDNF × 5-HTT × ELS)<sub>6</sub> + <italic>b</italic><sub>7</sub>(age)<sub>7</sub> + <italic>b</italic><sub>8</sub>(gender)<sub>8</sub>. The BDNF and 5-HTT alleles were coded as a binary variable (BDNF Val66Met: V66M:VV versus (VM or MM); 5-HTTPLR:LL versus (SL or SS)) to examine the effects of the BDNF M allele and 5-HTT S allele as vulnerability factors. In order to confirm our hypothesis that variance could not be better explained by a diagnosis of MDD regardless of subtype, regression models were also tested contrasting CTRL and MDD (NMEL + MEL) (reference categories of 0 and 1, respectively). Significant effects were set at <italic>p</italic> &lt; 0.05, while findings were labelled as trends if <italic>p</italic> &lt; 0.1 and <italic>p</italic> &gt; 0.05.</p>
</sec></sec>
<sec id="section7-0004867411430878" sec-type="results">
<title>Results</title>
<sec id="section8-0004867411430878">
<title>Clinical data</title>
<p>Significant differences were observed between groups (MEL, NMEL, CTRL) on the HRSD (F(2) = 844.671, <italic>p</italic> &lt; 0.001), DASS-D (F(2) = 4633.332, <italic>p</italic> &lt; 0.001), DASS-A (F(2) = 103.463, <italic>p</italic> &lt; 0.001), DASS-S (F(2) = 255.588, <italic>p</italic> &lt; 0.001) and the CORE total score (F(2) = 77.247, <italic>p</italic> &lt; 0.001), such that patients with melancholia displayed increased scores on all measures than those with non-melancholia and controls, respectively (see <xref ref-type="table" rid="table1-0004867411430878">Table 1</xref> for means and standard deviations of clinical data). Increased levels of depression severity, psychomotor disturbance and anxious arousal are consistent with current conceptualisations of melancholia (<xref ref-type="bibr" rid="bibr22-0004867411430878">Gold and Chrousos, 2002</xref>; <xref ref-type="bibr" rid="bibr29-0004867411430878">Hickie, 1996</xref>). There were no significant differences for diagnostic group (MEL, NMEL, CTRL) on gender (χ<sup>2</sup>(2) = 1.345, <italic>p</italic> = 0.510) or age (F(2) = 1.401, <italic>p</italic> = 0.248) (see <xref ref-type="table" rid="table1-0004867411430878">Table 1</xref> for age and gender demographics).</p>
<table-wrap id="table1-0004867411430878" position="float">
<label>Table 1.</label>
<caption><p>Mean and standard deviations (M ± SD) of clinical data by group, including age, gender, and early life stress demographics.</p></caption>
<graphic alternate-form-of="table1-0004867411430878" xlink:href="10.1177_0004867411430878-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="left">Age</th>
<th align="left">Gender (M/F)</th>
<th align="left">ELS</th>
<th align="left">HRSD</th>
<th align="left">DASS-D</th>
<th align="left">DASS-A</th>
<th align="left">DASS-S</th>
<th align="left">CORE</th>
</tr>
</thead>
<tbody>
<tr>
<td>MEL</td>
<td>42.07 ± 16.14</td>
<td>24 (35.8%) / 43 (64.1%)</td>
<td>4.46 ± 3.80</td>
<td>21.80 ± 4.69</td>
<td>28.93 ± 8.95</td>
<td>14.54 ± 9.80</td>
<td>22.72 ± 8.90</td>
<td>7.10 ± 6.09</td>
</tr>
<tr>
<td>NMEL</td>
<td>37.89 ± 12.38</td>
<td>28 (45.9%) / 33 (54.1%)</td>
<td>3.02 ± 3.28</td>
<td>18.87 ± 5.31</td>
<td>26.26 ± 8.95</td>
<td>10.59 ± 6.89</td>
<td>19.51 ± 6.83</td>
<td>3.72 ± 3.11</td>
</tr>
<tr>
<td>CTRL</td>
<td>40.06 ± 14.55</td>
<td>52 (40.6%) / 76 (59.4%)</td>
<td>1.60 ± 2.04</td>
<td>.29 ± 0.72</td>
<td>2.21 ± 3.18</td>
<td>1.67 ± 2.61</td>
<td>3.63 ± 3.88</td>
<td>0.00 ± 0.00</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0004867411430878">
<p>ELS: early life stress; HRSD: Hamilton Rating Scale for Depression; DASS: Depression, Anxiety and Stress Scales; CORE: CORE Assessment of Psychomotor Change; MEL: melancholic; NMEL: non-melancholic; CTRL: control.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section9-0004867411430878">
<title>Group characteristics: early life stress</title>
<p>There were significant differences across diagnostic groups (MEL, NMEL, CTRL) for the total number of ELS events (F(2) = 22.103, <italic>p</italic> &lt; 0.001). The melancholic group had a greater number of ELS events (mean = 4.463, SD = 3.795), followed by the non-melancholic (mean = 3.016, SD = 3.279) and control (mean = 1.594, SD = 2.037) groups. The number of ELS events differed significantly between all groups (melancholic versus non-melancholic patients: MD = 1.446, SD = 0.513, Tukey’s HSD, <italic>p</italic> &lt; 0.05; melancholic patients versus controls: MD = 2.869, SD = 0.437, <italic>p</italic> &lt; 0.001; and non-melancholic patients versus controls: MD = 1.423, SD = 0.451, <italic>p</italic> &lt; 0.01). The most common forms of ELS for the melancholic group were family conflict (47.8%), emotional abuse (46.3%), bullying (43.3%) and divorce (37.8%); for the non-melancholic group: domestic violence (32.8%), family conflict (32.8%), divorce (32.8%) and bullying (27.9%); and for controls: family conflict (14.8%), divorce (14.8%), emotional abuse (13.3%) and bullying (12.5%).</p>
</sec>
<sec id="section10-0004867411430878">
<title>Group characteristics: genotype</title>
<p>The genotype frequencies were for BDNF: 64.6% VV (<italic>n</italic> = 155), 31.3% VM (<italic>n</italic> = 75) and 4.2% MM (<italic>n</italic> = 10) and for 5-HTT: 30.8% LL (<italic>n</italic> = 74), 50.8% SL (<italic>n</italic> = 122) and 18.3% SS (<italic>n</italic> = 44). Both were in Hardy-Weinberg equilibrium (BDNF: χ<sup>2</sup>(1) = 0.06, <italic>p</italic> = 0.190; 5-HTT: χ<sup>2</sup>(1) = 0.26, <italic>p</italic> = 0.390). No significant relationships were revealed between genotype (BDNF: χ<sup>2</sup>(2) = 3.057, <italic>p</italic> = 0.217; 5-HTT: χ<sup>2</sup>(2) = 0.828, <italic>p</italic> = 0.661) and group (MEL, NMEL, CTRL). Genotype frequencies are listed in <xref ref-type="table" rid="table2-0004867411430878">Table 2</xref>.</p>
<table-wrap id="table2-0004867411430878" position="float">
<label>Table 2.</label>
<caption><p>Genotype frequencies and number of vulnerability alleles (i.e. BDNF Met allele and/or 5-HTT S allele) by group.</p></caption>
<graphic alternate-form-of="table2-0004867411430878" xlink:href="10.1177_0004867411430878-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="left" colspan="2">BDNF</th>
<th align="left" colspan="2">5-HTT</th>
</tr>
<tr>
<th/>
<th align="left">VV</th>
<th align="left">VM or MM</th>
<th align="left">LL</th>
<th align="left">SL or SS</th>
</tr>
</thead>
<tbody>
<tr>
<td>MEL</td>
<td>31 (55.4%)</td>
<td>25 (44.6%)</td>
<td>20 (35.7%)</td>
<td>36 (64.3%)</td>
</tr>
<tr>
<td>NMEL</td>
<td>38 (64.4%)</td>
<td>21 (35.6%)</td>
<td>17 (28.8%)</td>
<td>42 (71.2%)</td>
</tr>
<tr>
<td>CTRL</td>
<td>86 (68.8%)</td>
<td>39 (31.2%)</td>
<td>37 (29.6%)</td>
<td>88 (70.4%)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0004867411430878">
<p>MEL: melancholic; NMEL: non-melancholic; CTRL: control.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section11-0004867411430878">
<title>Relationship between genotype and subtype: mediation by early life stress</title>
<p>With 239 valid cases and age and gender entered as covariates, the <xref ref-type="bibr" rid="bibr54-0004867411430878">Preacher and Hayes (2008)</xref> bootstrap results for indirect effects demonstrated a significant ab path (genotype–environment), 95% bias corrected and accelerated confidence interval (0.010, 0.075). The summary for the subtype reference categories model was significant, F(4, 234) = 4.22, <italic>p</italic> = 0.003. The <italic>a</italic> path (β = −0.55, <italic>t</italic> = −2.717, <italic>p</italic> = 0.007) and <italic>b</italic> path (β = −0.070, <italic>t</italic> = −4.000, <italic>p</italic> &lt; 0.001) were significant. The <italic>c</italic> path (genotype–phenotype) was not significant (<italic>p</italic> = 0.667) but, as signified by the bootstrap results, <italic>c</italic>’ path was significantly less robust than the <italic>c</italic> path (<italic>p</italic> = 0.806). There were no significant effects of the covariates age (β = 0.001, <italic>t</italic> = 0.346, <italic>p</italic> = 0.730) and gender (β = −0.065, <italic>t</italic> = −0.605, <italic>p</italic> = 0.556) on the model. Therefore, the relationship between 5-HTTPLR × BDNF polymorphism combinations and subtype reference categories are mediated by an indirect effect of ELS (see <xref ref-type="fig" rid="fig1-0004867411430878">Figure 1</xref>).</p>
<fig id="fig1-0004867411430878" position="float">
<label>Figure 1.</label>
<caption>
<p>A mediation model of the indirect effect of early life stressors on the relationship between a 5-HTTPLR × BDNF and depression subtypes.</p>
</caption>
<graphic xlink:href="10.1177_0004867411430878-fig1.tif"/>
</fig>
</sec>
<sec id="section12-0004867411430878">
<title>The contribution of genotype and early life stress to depression heterogeneity</title>
<p>For the main and interaction effects, models BDNF × ELS, 5-HTT × ELS and BDNF × 5-HTT × ELS significantly contributed to non-melancholia relative to controls only (see <xref ref-type="table" rid="table3-0004867411430878">Table 3</xref>). Neither main nor interaction effects were found in the combined model for melancholia. The odds ratio revealed that an interaction between BDNF and ELS increased risk of non-melancholia by 3.327, whereas for the interaction between 5-HTT and ELS it was by 2.406. The interaction between BDNF, 5-HTT and ELS, whilst significant, only resulted in an odds ratio of 0.523. No variable was observed to contribute to the model comparing MDD patients (melancholic and non-melancholic depression combined) with controls.</p>
<table-wrap id="table3-0004867411430878" position="float">
<label>Table 3.</label>
<caption><p>Logistic regression values for non-melancholia versus controls.</p></caption>
<graphic alternate-form-of="table3-0004867411430878" xlink:href="10.1177_0004867411430878-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Non-melancholia: gene × environment factor</th>
<th align="left">B</th>
<th align="left">SE</th>
<th align="left">Wald</th>
<th align="left">Sig.</th>
<th align="left">OR</th>
</tr>
</thead>
<tbody>
<tr>
<td>BDNF × ELS</td>
<td>1.202</td>
<td>0.606</td>
<td>3.939</td>
<td><italic>p</italic> = 0.047</td>
<td>3.327</td>
</tr>
<tr>
<td>5-HTT × ELS</td>
<td>0.878</td>
<td>0.399</td>
<td>4.840</td>
<td><italic>p</italic> = 0.028</td>
<td>2.406</td>
</tr>
<tr>
<td>BDNF × 5-HTT × ELS</td>
<td>0.648</td>
<td>0.310</td>
<td>4.364</td>
<td><italic>p</italic> = 0.037</td>
<td>0.523</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-0004867411430878">
<p>ELS: early life stress.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="section13-0004867411430878" sec-type="discussion">
<title>Discussion</title>
<p>The current study reveals that the BDNF and 5-HTT genotypes contribute to increased risk for non-melancholia, but not melancholia, when an individual is exposed to ELS. Contrary to our expectations, depressed patients with BDNF Met and 5-HTT S alleles are more likely to meet criteria for non-melancholic depression rather than melancholia. These preliminary findings indicate that different combinations of genotype may affect the phenotype of depression. The 5-HTT S allele may contribute to symptoms of depression (i.e. depressed mood, sleep irregularities and appetite alterations) congruent with both subtypes (<xref ref-type="bibr" rid="bibr45-0004867411430878">Malhi et al., 2005b</xref>; <xref ref-type="bibr" rid="bibr49-0004867411430878">Nutt, 2008</xref>), while the Met allele may contribute to the additional symptoms observed in more severe cases of depression that may require pharmacological treatment (i.e. working memory and executive cognitive dysfunction) (<xref ref-type="bibr" rid="bibr52-0004867411430878">Parker et al., 2001</xref>; <xref ref-type="bibr" rid="bibr63-0004867411430878">Stewart et al., 1989</xref>) in the context of ELS. Interestingly, prior research has indicated that personality dysfunction may contribute to non-melancholia compared to melancholia (<xref ref-type="bibr" rid="bibr57-0004867411430878">Rubino et al., 2009</xref>), and such dysfunction may relate to 5-HTT and BDNF polymorphisms. The 5-HTT S allele may be a genetic substrate for the latent personality trait, neuroticism (or negative affectivity), and psychopathology in individuals with this vulnerability allele may develop under conditions of stress (<xref ref-type="bibr" rid="bibr7-0004867411430878">Caspi et al., 2010</xref>). Furthermore, we have previously reported (<xref ref-type="bibr" rid="bibr21-0004867411430878">Gatt et al., 2009</xref>) that an interaction between the BDNF Met allele and ELS may lead to higher levels of neuroticism and higher depression through bodily arousal. It is important to note that we are not concluding that there is no genetic basis to the melancholic subtype. Instead, we suggest that melancholia may involve other mechanisms not investigated in this study. Alternatively, it is possible that the lack of findings for patients with melancholia reflects a Type II error due to small sample size. Regardless, an important conclusion that can be drawn from the findings reported here is that non-melancholia may well have an underlying biological basis, consistent with structural and functional models of depression (<xref ref-type="bibr" rid="bibr45-0004867411430878">Malhi et al., 2005b</xref>).</p>
<p>While the Met and S alleles provide a vulnerability to the non-melancholic subtype, their link to reduced function only predicts non-melancholia in combination with ELS, consistent with increasing recognition of the interaction between genetic and environmental factors (<xref ref-type="bibr" rid="bibr35-0004867411430878">Kaufman et al., 2006</xref>). We observed that while ELS contributes to both melancholic and non-melancholic depression, patients with the melancholic subtype experience a greater number of ELS events (i.e. overall melancholic patients have more ELS). This further suggests that there are mechanisms other than BDNF and 5-HTT vulnerabilities alongside ELS that contribute to melancholic depression. Indeed, antidepressants that modulate both serotonin and norepinephrine are more efficacious in patients with melancholia (<xref ref-type="bibr" rid="bibr44-0004867411430878">Malhi et al., 2005a</xref>), while non-melancholic patients respond well to antidepressants modulating only serotonin (<xref ref-type="bibr" rid="bibr48-0004867411430878">National Institute for Clinical Excellence, 2004</xref>). Anhedonia symptoms have also been linked to deficits in the dopamine neurotransmitter system, which may be specific to melancholia (<xref ref-type="bibr" rid="bibr44-0004867411430878">Malhi et al., 2005a</xref>; <xref ref-type="bibr" rid="bibr62-0004867411430878">Stein, 2008</xref>).</p>
<p>The presence of the BDNF Met allele may also contribute to non-melancholia considering its influence on both serotonin and norepinephrine production (<xref ref-type="bibr" rid="bibr59-0004867411430878">Santarelli et al., 2003</xref>). The Met allele of the BDNF polymorphism has been linked to lower levels of activity-dependent secretion (<xref ref-type="bibr" rid="bibr18-0004867411430878">Egan et al., 2003</xref>) along with deficiencies in neuropsychological performance tasks (<xref ref-type="bibr" rid="bibr16-0004867411430878">Dempster et al., 2005</xref>; <xref ref-type="bibr" rid="bibr18-0004867411430878">Egan et al., 2003</xref>; <xref ref-type="bibr" rid="bibr19-0004867411430878">Gatt et al., 2007</xref>; <xref ref-type="bibr" rid="bibr25-0004867411430878">Hariri et al., 2003</xref>; <xref ref-type="bibr" rid="bibr27-0004867411430878">Hasler et al., 2004</xref>; <xref ref-type="bibr" rid="bibr46-0004867411430878">Mayberg, 1997</xref>; <xref ref-type="bibr" rid="bibr58-0004867411430878">Rybakowski et al., 2003</xref>). These functions, such as working memory and executive cognitive functioning contribute to resilience and effective coping mechanisms. Thus, when a Met carrier is exposed to ELS (i.e. environmental factors) they are potentially less able to utilise problem-solving strategies to manage their distress leading to a non-melancholic depression. This is also consistent with findings that repeated exposure to ELS leads to neuronal loss in regions consistently implicated in depression (<xref ref-type="bibr" rid="bibr28-0004867411430878">Heim and Nemeroff, 1999</xref>); areas which have been shown to be directly affected by BDNF (<xref ref-type="bibr" rid="bibr5-0004867411430878">Black, 1999</xref>; <xref ref-type="bibr" rid="bibr15-0004867411430878">Conner et al., 1997</xref>; <xref ref-type="bibr" rid="bibr55-0004867411430878">Rattiner et al., 2004</xref>). BDNF is thus required as a protective factor against neuronal atrophy. Hence, a reduction of BDNF in non-melancholic depression may lead to neurocognitive deficits that in turn lead to reduced coping abilities in the context of stress. As the production of serotonin has been linked to changes in BDNF (<xref ref-type="bibr" rid="bibr47-0004867411430878">Munafo et al., 2005</xref>; <xref ref-type="bibr" rid="bibr65-0004867411430878">Urani et al., 2005</xref>), this relationship may be specific to non-melancholia such that stress precipitates a disruption in neural circuitry in those individuals with 5-HTT and BDNF vulnerability. Indeed, Met alleles and S alleles have previously predicted an increased risk for depression in maltreated children when ELS is considered (<xref ref-type="bibr" rid="bibr35-0004867411430878">Kaufman et al., 2006</xref>; see also <xref ref-type="bibr" rid="bibr26-0004867411430878">Harkness and Monroe, 2006</xref>). Previous research has also demonstrated that higher levels of stress sensitivity are associated with lower influence of negative life events on future episodes of depression (<xref ref-type="bibr" rid="bibr66-0004867411430878">Wichers et al., 2009</xref>). This may be due to sensitisation that leads to more autonomous onsets of depression later in life (i.e. the kindling hypothesis (<xref ref-type="bibr" rid="bibr39-0004867411430878">Kendler et al., 2000</xref>; <xref ref-type="bibr" rid="bibr53-0004867411430878">Post, 1992</xref>)). The kindling hypothesis proposes that the neurobiology of affective disorders changes as a function of exposure to stress and time (<xref ref-type="bibr" rid="bibr39-0004867411430878">Kendler et al., 2000</xref>). Our results support this proposal for non-melancholic depression in particular, a disorder associated with generally less severe depression and younger age of onset; and that this effect may be driven by vulnerability in BDNF and 5-HTT polymorphisms, exacerbated by repeated exposure to ELS.</p>
<p>The key finding from the current study is that BDNF and 5-HTT polymorphisms contribute to the development of non-melancholic depression after exposure to ELS. It is possible that non-melancholic patients have difficulties utilising effective coping mechanisms which may contribute to further reductions in resilience after exposure to ELS. The combination of these genetic risk factors and environmental predisposition toward stress may contribute to depression with non-melancholia but not melancholia. However, the number of ELS events may play a greater role in the development of melancholia than in non-melancholia. We further suggest there may be alternative genetic mechanisms contributing to the development of the melancholic subtype that were not examined in this study. With further research, additional contributing factors such as neuropsychological function and psychophysiological substrates of depression subtypes could be examined.</p>
<p>The current study has a number of limitations. First, we restricted our focus to 5-HTT and BDNF genotypes, and the lack of results for patients with melancholia indicates that additional genetic mechanisms may be involved. Second, the preliminary nature of our findings should be noted and the limitations of a small sample size considered. However, we suggest that a lack of study power as a function of a small sample size is usually associated with false negatives (i.e. a Type II error) rather than false positives (i.e. a Type I error). Our findings therefore support a role for genetic factors in the development of non-melancholia. Future studies should further examine differential gene × environment interactions that may underlie melancholia versus non-melancholia, rather than patients diagnosed with MDD per se.</p>
</sec>
</body>
<back>
<ack>
<p>We also acknowledge the data and support provided by BRAINnet; <ext-link ext-link-type="uri" xlink:href="http://www.BRAINnet.net">www.BRAINnet.net</ext-link>, under the governance of the BRAINnet Foundation. BRAINnet is the scientific network that coordinates access to the Brain Resource International Database for independent scientific purposes.</p>
<p>Sponsors played no role in analysis and interpretation of data, writing of the manuscript or in the decision to submit the paper for publication.</p>
<p>The authors CRQ, TO and AHK had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis</p>
</ack>
<sec id="section14-0004867411430878">
<title>Funding</title>
<p>CRQ and TO were supported by an Australian Postgraduate Award, and AHK by a National Health and Medical Research Council Career Development Award Fellowship (571101). This research was supported by a National Health and Medical Research Council (NHMRC) Project Grant (464863) and an Australian Research Council Discovery Grant (DP0987332).</p>
</sec>
<sec id="section15-0004867411430878">
<title>Declaration of interest</title>
<p>AH has been awarded research funding from the NHMRC, Australian Rotary, Perpetual Trustees, Eli Lilly Australia, Janssen-Cilag Australia and the Schizophrenia Fellowship of NSW. AWFH has also received consultancy fees from Organon Australia, Eli Lilly and Lundbeck Australia. AWFH has received payments for educational sessions run for Astra Zeneca, Janssen-Cilag, Eli Lilly and Organon. AWFH has also run educational sessions for a number of medical education companies including Wellmark Australia, Reed Business Information and CME LLC.</p>
<p>Johnson and Johnson Pharmaceutical Research and Development, RED Europe also supported the project from which data in the current study were drawn.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="bibr1-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Acheson</surname><given-names>A</given-names></name>
<name><surname>Conover</surname><given-names>JC</given-names></name>
<name><surname>Fandl</surname><given-names>JP</given-names></name><etal/>
</person-group>. (<year>1995</year>) <article-title>A BDNF autocrine loop in adult sensory neurons prevents cell death</article-title>. <source>Nature</source> <volume>374</volume>(<issue>6521</issue>): <fpage>450</fpage>–<lpage>453</lpage>.</citation>
</ref>
<ref id="bibr2-0004867411430878">
<citation citation-type="book">
<collab>American Psychiatric Association</collab> (<year>2000</year>) <source>Diagnostic and Statistical Manual of Mental Disorders</source>, <edition>4th edition</edition> (text revision). <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Psychiatric Association</publisher-name>.</citation>
</ref>
<ref id="bibr3-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Beevers</surname><given-names>CG</given-names></name>
<name><surname>Wells</surname><given-names>TT</given-names></name>
<name><surname>McGeary</surname><given-names>JE</given-names></name>
</person-group> (<year>2009</year>) <article-title>The BDNF Val66Met polymorphism is associated with rumination in healthy adults</article-title>. <source>Emotion</source> <volume>9</volume>(<issue>4</issue>): <fpage>579</fpage>–<lpage>584</lpage>.</citation>
</ref>
<ref id="bibr4-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Belmaker</surname><given-names>RH</given-names></name>
<name><surname>Agam</surname><given-names>G</given-names></name>
</person-group> (<year>2008</year>) <article-title>Major depressive disorder</article-title>. <source>New England Journal of Medicine</source> <volume>358</volume>: <fpage>55</fpage>–<lpage>68</lpage>.</citation>
</ref>
<ref id="bibr5-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Black</surname><given-names>IB</given-names></name>
</person-group> (<year>1999</year>) <article-title>Trophic regulation of synaptic plasticity</article-title>. <source>Journal of Neurobiology</source> <volume>41</volume>(<issue>1</issue>): <fpage>108</fpage>–<lpage>118</lpage>.</citation>
</ref>
<ref id="bibr6-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brunoni</surname><given-names>AR</given-names></name>
<name><surname>Lopes</surname><given-names>M</given-names></name>
<name><surname>Fregni</surname><given-names>F</given-names></name>
</person-group> (<year>2008</year>) <article-title>A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression</article-title>. <source>International Journal of Neuropsychopharmacology</source> <volume>28</volume>: <fpage>1</fpage>–<lpage>12</lpage>.</citation>
</ref>
<ref id="bibr7-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Caspi</surname><given-names>A</given-names></name>
<name><surname>Hariri</surname><given-names>A</given-names></name>
<name><surname>Holmes</surname><given-names>A</given-names></name><etal/>
</person-group>. (<year>2010</year>) <article-title>Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits</article-title>. <source>American Journal of Psychiatry</source> <volume>167</volume>(<issue>5</issue>): <fpage>509</fpage>–<lpage>527</lpage>.</citation>
</ref>
<ref id="bibr8-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Caspi</surname><given-names>A</given-names></name>
<name><surname>Sugden</surname><given-names>K</given-names></name>
<name><surname>Moffitt</surname><given-names>TE</given-names></name><etal/>
</person-group>. (<year>2003</year>) <article-title>Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene</article-title>. <source>Science</source> <volume>301</volume>: <fpage>386</fpage>–<lpage>389</lpage>.</citation>
</ref>
<ref id="bibr9-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Castren</surname><given-names>E</given-names></name>
</person-group> (<year>2004</year>) <article-title>Neurotrophic effects of antidepressant drugs</article-title>. <source>Current Opinion in Pharmacology</source> <volume>4</volume>(<issue>1</issue>): <fpage>58</fpage>–<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr10-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Castren</surname><given-names>E</given-names></name>
</person-group> (<year>2005</year>) <article-title>Is mood chemistry?</article-title> <source>Nature Reviews Neuroscience</source> <volume>6</volume>(<issue>3</issue>): <fpage>241</fpage>–<lpage>246</lpage>.</citation>
</ref>
<ref id="bibr11-0004867411430878">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name><surname>Cervilla</surname><given-names>JA</given-names></name>
<name><surname>Molina</surname><given-names>E</given-names></name>
<name><surname>Rivera</surname><given-names>M</given-names></name>
</person-group> (<year>2007</year>) <article-title>The risk for depression conferred by stressful life events is modified by variation at the serotonin transporter 5-HTTPLR genotype: evidence from the Spanish PREDICT-Gene cohort</article-title>. <source>Molecular Psychiatry</source> <volume>12</volume>(<issue>8</issue>): <fpage>746</fpage>–<lpage>755</lpage>.</citation>
</ref>
<ref id="bibr12-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>B</given-names></name>
<name><surname>Dowlatshahi</surname><given-names>D</given-names></name>
<name><surname>MacQueen</surname><given-names>GM</given-names></name><etal/>
</person-group>. (<year>2001</year>) <article-title>Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication</article-title>. <source>Biological Psychiatry</source> <volume>50</volume>(<issue>4</issue>): <fpage>260</fpage>–<lpage>265</lpage>.</citation>
</ref>
<ref id="bibr13-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>B</given-names></name>
<name><surname>Lawlor</surname><given-names>DA</given-names></name>
<name><surname>Lewis</surname><given-names>SJ</given-names></name><etal/>
</person-group>. (<year>2008</year>) <article-title>Genetic association study of BDNF in depression: finding from two cohort studies and a meta-analysis</article-title>. <source>American Journal of Medical Genetics Part B: Neuropsychiatric Genetics</source> <volume>147B</volume>(<issue>6</issue>): <fpage>814</fpage>–<lpage>821</lpage>.</citation>
</ref>
<ref id="bibr14-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cohen</surname><given-names>RA</given-names></name>
<name><surname>Paul</surname><given-names>RH</given-names></name>
<name><surname>Stroud</surname><given-names>L</given-names></name><etal/>
</person-group>. (<year>2006</year>) <article-title>Early life stress and adult emotional experience: an international perspective</article-title>. <source>International Journal of Psychiatric Medicine</source> <volume>36</volume>: <fpage>35</fpage>–<lpage>52</lpage>.</citation>
</ref>
<ref id="bibr15-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Conner</surname><given-names>JM</given-names></name>
<name><surname>Lauterborn</surname><given-names>JC</given-names></name>
<name><surname>Yan</surname><given-names>Q</given-names></name><etal/>
</person-group>. (<year>1997</year>) <article-title>Distribution of Brain-Derived Neurotrophic Factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport</article-title>. <source>Journal of Neuroscience</source> <volume>17</volume>(<issue>7</issue>): <fpage>2295</fpage>–<lpage>2313</lpage>.</citation>
</ref>
<ref id="bibr16-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dempster</surname><given-names>E</given-names></name>
<name><surname>Toulopoulou</surname><given-names>T</given-names></name>
<name><surname>McDonald</surname><given-names>C</given-names></name><etal/>
</person-group>. (<year>2005</year>) <article-title>Association between BDNF val66 met genotype and episodic memory</article-title>. <source>American Journal of Medical Genetics Part B: Neuropsychiatric Genetics</source> <volume>134B</volume>: <fpage>73</fpage>–<lpage>75</lpage>.</citation>
</ref>
<ref id="bibr17-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Duman</surname><given-names>RS</given-names></name>
<name><surname>Monteggia</surname><given-names>LM</given-names></name>
</person-group> (<year>2006</year>) <article-title>A neurotrophic model for stress-related mood disorders</article-title>. <source>Biological Psychiatry</source> <volume>59</volume>(<issue>12</issue>): <fpage>1116</fpage>–<lpage>1127</lpage>.</citation>
</ref>
<ref id="bibr18-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Egan</surname><given-names>MF</given-names></name>
<name><surname>Kojima</surname><given-names>M</given-names></name>
<name><surname>Callicott</surname><given-names>JH</given-names></name><etal/>
</person-group>. (<year>2003</year>) <article-title>The BDNF val66met polymorphism affects activity-dependant secretion of BDNF and human memory and hippocampul functioning</article-title>. <source>Cell</source> <volume>112</volume>: <fpage>257</fpage>–<lpage>269</lpage>.</citation>
</ref>
<ref id="bibr19-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gatt</surname><given-names>JM</given-names></name>
<name><surname>Clark</surname><given-names>CR</given-names></name>
<name><surname>Kemp</surname><given-names>AH</given-names></name><etal/>
</person-group>. (<year>2007</year>) <article-title>A genotype-endophenotype-phenotype path model of depressed mood: integrating cognitive and emotional markers</article-title>. <source>Journal of Integrative Neuroscience</source> <volume>6</volume>(<issue>1</issue>): <fpage>75</fpage>–<lpage>104</lpage>.</citation>
</ref>
<ref id="bibr20-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gatt</surname><given-names>JM</given-names></name>
<name><surname>Kuan</surname><given-names>SA</given-names></name>
<name><surname>Dobson-Stone</surname><given-names>C</given-names></name><etal/>
</person-group>. (<year>2008</year>) <article-title>Association between BDNF Val66Met polymorphism and trait depression is mediated by resting EEG alpha band activity</article-title>. <source>Biological Psychology</source> <volume>79</volume>(<issue>2</issue>): <fpage>275</fpage>–<lpage>284</lpage>.</citation>
</ref>
<ref id="bibr21-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gatt</surname><given-names>JM</given-names></name>
<name><surname>Nemeroff</surname><given-names>CB</given-names></name>
<name><surname>Dobsone-Stone</surname><given-names>C</given-names></name><etal/>
</person-group>. (<year>2009</year>) <article-title>Interactions between BDNF Val66Met polymorphism and early life stress predict brain arousal pathways to syndromal depression and anxiety</article-title>. <source>Molecular Psychiatry</source> <volume>14</volume>: <fpage>681</fpage>–<lpage>691</lpage>.</citation>
</ref>
<ref id="bibr22-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gold</surname><given-names>PW</given-names></name>
<name><surname>Chrousos</surname><given-names>GP</given-names></name>
</person-group> (<year>2002</year>) <article-title>Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states</article-title>. <source>Molecular Psychiatry</source> <volume>7</volume>(<issue>3</issue>): <fpage>254</fpage>–<lpage>275</lpage>.</citation>
</ref>
<ref id="bibr23-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gordon</surname><given-names>E</given-names></name>
<name><surname>Cooper</surname><given-names>N</given-names></name>
<name><surname>Rennie</surname><given-names>C</given-names></name><etal/>
</person-group>. (<year>2005</year>) <article-title>Integrative neuroscience: the role of a standardised database</article-title>. <source>Clinical EEG Neurosciences</source> <volume>36</volume>: <fpage>64</fpage>–<lpage>75</lpage>.</citation>
</ref>
<ref id="bibr24-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hamilton</surname><given-names>M</given-names></name>
</person-group> (<year>1960</year>) <article-title>A rating scale for depression</article-title>. <source>Journal of Neurology Neurosurgery Psychiatry</source> <volume>3</volume>(<issue>1</issue>): <fpage>56</fpage>–<lpage>62</lpage>.</citation>
</ref>
<ref id="bibr25-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hariri</surname><given-names>AR</given-names></name>
<name><surname>Goldberg</surname><given-names>TE</given-names></name>
<name><surname>Mattay</surname><given-names>VS</given-names></name><etal/>
</person-group>. (<year>2003</year>) <article-title>Brain-derived neurotrophic factor val-66met polymorphism affects human memory-related hippocampal activity and predicts memory performance</article-title>. <source>Journal of Neuroscience</source> <volume>23</volume>: <fpage>6690</fpage>–<lpage>6694</lpage>.</citation>
</ref>
<ref id="bibr26-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Harkness</surname><given-names>KL</given-names></name>
<name><surname>Monroe</surname><given-names>SM</given-names></name>
</person-group> (<year>2006</year>) <article-title>Severe melancholic depression is more vulnerable than non-melancholic depression to minor precipitating events</article-title>. <source>Journal of Affective Disorders</source> <volume>91</volume>: <fpage>257</fpage>–<lpage>263</lpage>.</citation>
</ref>
<ref id="bibr27-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hasler</surname><given-names>G</given-names></name>
<name><surname>Drevets</surname><given-names>WC</given-names></name>
<name><surname>Manji</surname><given-names>HK</given-names></name><etal/>
</person-group>. (<year>2004</year>) <article-title>Discovering endophenotypes for major depression</article-title>. <source>Neuropsychopharmacology</source> <volume>29</volume>(<issue>10</issue>): <fpage>1765</fpage>–<lpage>1781</lpage>.</citation>
</ref>
<ref id="bibr28-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Heim</surname><given-names>C</given-names></name>
<name><surname>Nemeroff</surname><given-names>CB</given-names></name>
</person-group> (<year>1999</year>) <article-title>The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders</article-title>. <source>Biological Psychiatry</source> <volume>46</volume>: <fpage>1509</fpage>–<lpage>1522</lpage>.</citation>
</ref>
<ref id="bibr29-0004867411430878">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Hickie</surname><given-names>I</given-names></name>
</person-group> (<year>1996</year>) <article-title>Validity of the CORE: II. Neuropsychological tests</article-title>. In: <person-group person-group-type="editor">
<name><surname>Parker</surname><given-names>G</given-names></name>
<name><surname>Hadzi-Pavlovic</surname><given-names>D</given-names></name>
</person-group> (eds) <source>Melancholia: A Disorder of Movement and Mood</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Cambridge University Press</publisher-name>, pp.<fpage>149</fpage>–<lpage>159</lpage>.</citation>
</ref>
<ref id="bibr30-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Huang</surname><given-names>EJ</given-names></name>
<name><surname>Reichardt</surname><given-names>LF</given-names></name>
</person-group> (<year>2001</year>) <article-title>Neurotrophins: roles in neuronal development and function</article-title>. <source>Annual Review Neuroscience</source> <volume>24</volume>: <fpage>677</fpage>–<lpage>736</lpage>.</citation>
</ref>
<ref id="bibr31-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hwang</surname><given-names>JP</given-names></name>
<name><surname>Tsai</surname><given-names>SJ</given-names></name>
<name><surname>Hong</surname><given-names>CJ</given-names></name><etal/>
</person-group>. (<year>2006</year>) <article-title>Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression</article-title>. <source>Neurobiology of Aging</source> <volume>27</volume>: <fpage>1834</fpage>–<lpage>1837</lpage>.</citation>
</ref>
<ref id="bibr32-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jacobs</surname><given-names>N</given-names></name>
<name><surname>Kenis</surname><given-names>G</given-names></name>
<name><surname>Peeters</surname><given-names>F</given-names></name><etal/>
</person-group>. (<year>2006</year>) <article-title>Stress-related negative affectivity and genetically altered serotonin function</article-title>. <source>Archives of General Psychiatry</source> <volume>63</volume>: <fpage>989</fpage>–<lpage>996</lpage>.</citation>
</ref>
<ref id="bibr33-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jiang</surname><given-names>X</given-names></name>
<name><surname>Xu</surname><given-names>X</given-names></name>
<name><surname>Hoberman</surname><given-names>J</given-names></name><etal/>
</person-group>. (<year>2005</year>) <article-title>BDNF variation and mood disorders: a novel function promoter polymorphism and val66met are associated with anxiety but having opposing effects</article-title>. <source>Neuropsychopharmacology</source> <volume>30</volume>: <fpage>1353</fpage>–<lpage>1361</lpage>.</citation>
</ref>
<ref id="bibr34-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Karege</surname><given-names>F</given-names></name>
<name><surname>Bondolfi</surname><given-names>G</given-names></name>
<name><surname>Gervasoni</surname><given-names>N</given-names></name><etal/>
</person-group>. (<year>2005</year>) <article-title>Low Brain-Derived Neurotrophic Factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity</article-title>. <source>Biological Psychiatry</source> <volume>57</volume>(<issue>9</issue>): <fpage>1068</fpage>–<lpage>1072</lpage>.</citation>
</ref>
<ref id="bibr35-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kaufman</surname><given-names>J</given-names></name>
<name><surname>Yang</surname><given-names>BZ</given-names></name>
<name><surname>Douglas-Palumberi</surname><given-names>H</given-names></name><etal/>
</person-group>. (<year>2006</year>) <article-title>Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children</article-title>. <source>Biological Psychiatry</source> <volume>59</volume>: <fpage>673</fpage>–<lpage>680</lpage>.</citation>
</ref>
<ref id="bibr36-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kemp</surname><given-names>AH</given-names></name>
<name><surname>Gordon</surname><given-names>E</given-names></name>
<name><surname>Rush</surname><given-names>AJ</given-names></name><etal/>
</person-group>. (<year>2008</year>) <article-title>Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging and genetic measures</article-title>. <source>CNS Spectrum</source> <volume>13</volume>(<issue>12</issue>): <fpage>1066</fpage>–<lpage>1086</lpage>.</citation>
</ref>
<ref id="bibr37-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kendler</surname><given-names>KS</given-names></name>
<name><surname>Kuhn</surname><given-names>JW</given-names></name>
<name><surname>Vittum</surname><given-names>J</given-names></name><etal/>
</person-group>. (<year>2005</year>) <article-title>The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of major depression: a replication</article-title>. <source>Archives of General Psychiatry</source> <volume>52</volume>(<issue>5</issue>): <fpage>529</fpage>–<lpage>535</lpage>.</citation>
</ref>
<ref id="bibr38-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kendler</surname><given-names>K</given-names></name>
<name><surname>Neale</surname><given-names>M</given-names></name>
<name><surname>Kessler</surname><given-names>R</given-names></name><etal/>
</person-group>. (<year>1993</year>) <article-title>A test of the equal-environment assumption in twin studies of psychiatric illness</article-title>. <source>Behavior Genetics</source> <volume>23</volume>: <fpage>21</fpage>–<lpage>27</lpage>.</citation>
</ref>
<ref id="bibr39-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kendler</surname><given-names>KS</given-names></name>
<name><surname>Thornton</surname><given-names>LM</given-names></name>
<name><surname>Gardner</surname><given-names>CO</given-names></name>
</person-group> (<year>2000</year>) <article-title>Stressful life events and previous episodes in the eitiology of major depression in women: an evaluation of the ‘kindling’ hypothesis</article-title>. <source>American Journal of Psychiatry</source> <volume>157</volume>: <fpage>1243</fpage>–<lpage>1251</lpage>.</citation>
</ref>
<ref id="bibr40-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>JM</given-names></name>
<name><surname>Stewart</surname><given-names>R</given-names></name>
<name><surname>Kim</surname><given-names>SW</given-names></name>
</person-group> (<year>2007</year>) <article-title>Interactions between life stressors and susceptibility genes (5-HTTPLR and BDNF) on depression in Korean elders</article-title>. <source>Biological Psychiatry</source> <volume>62</volume>(<issue>5</issue>): <fpage>423</fpage>–<lpage>428</lpage>.</citation>
</ref>
<ref id="bibr41-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lesch</surname><given-names>K</given-names></name>
<name><surname>Bengel</surname><given-names>D</given-names></name>
<name><surname>Helis</surname><given-names>A</given-names></name><etal/>
</person-group>. (<year>1996</year>) <article-title>Association of anxiety related traits with a polymorphism in the serotonin transporter gene regulatory region</article-title>. <source>Science</source> <volume>274</volume>: <fpage>1527</fpage>–<lpage>1531</lpage>.</citation>
</ref>
<ref id="bibr42-0004867411430878">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Levinson</surname><given-names>D</given-names></name>
</person-group> (<year>2009</year>) <article-title>Genetics of major depression</article-title>. In: <person-group person-group-type="editor">
<name><surname>Gotlib</surname><given-names>IH</given-names></name>
<name><surname>Hammen</surname><given-names>CL</given-names></name>
</person-group> (eds) <source>Handbook of Depression</source>, <edition>second edition</edition>. <publisher-loc>New York</publisher-loc>: <publisher-name>The Guildford Press</publisher-name>, pp.<fpage>165</fpage>–<lpage>186</lpage>.</citation>
</ref>
<ref id="bibr43-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lovibond</surname><given-names>P</given-names></name>
<name><surname>Lovibond</surname><given-names>S</given-names></name>
</person-group> (<year>1995</year>) <article-title>The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression Inventories</article-title>. <source>Behavior Research and Therapy</source> <volume>33</volume>(<issue>3</issue>): <fpage>335</fpage>–<lpage>343</lpage>.</citation>
</ref>
<ref id="bibr44-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Malhi</surname><given-names>GS</given-names></name>
<name><surname>Parker</surname><given-names>GB</given-names></name>
<name><surname>Crawford</surname><given-names>J</given-names></name><etal/>
</person-group>. (<year>2005</year>) <article-title>Treatment-resistant depression: resistant to definition?</article-title> <source>Acta Psychiatrica Scandinavica</source> <volume>112</volume>(<issue>4</issue>): <fpage>302</fpage>–<lpage>309</lpage>.</citation>
</ref>
<ref id="bibr45-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Malhi</surname><given-names>GS</given-names></name>
<name><surname>Parker</surname><given-names>GB</given-names></name>
<name><surname>Greenwood</surname><given-names>J</given-names></name>
</person-group> (<year>2005b</year>) <article-title>Structural and functional models of depression: from sub-types to substrates</article-title>. <source>Acta Psychiatrica Scandinavica</source> <volume>111</volume>(<issue>2</issue>): <fpage>94</fpage>–<lpage>105</lpage>.</citation>
</ref>
<ref id="bibr46-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mayberg</surname><given-names>HS</given-names></name>
</person-group> (<year>1997</year>) <article-title>Limbic-cortical dysregulation: a proposed model of depression</article-title>. <source>Journal of Neuropsychiatric Clinical Neuroscience</source> <volume>9</volume>: <fpage>471</fpage>–<lpage>481</lpage>.</citation>
</ref>
<ref id="bibr47-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Munafo</surname><given-names>MR</given-names></name>
<name><surname>Clark</surname><given-names>T</given-names></name>
<name><surname>Flint</surname><given-names>J</given-names></name>
</person-group> (<year>2005</year>) <article-title>Does measurement instrument moderate the association between the serotonin transporter gene and anxiety-related personality traits? A meta analysis</article-title>. <source>Molecular Psychiatry</source> <volume>10</volume>: <fpage>415</fpage>–<lpage>419</lpage>.</citation>
</ref>
<ref id="bibr48-0004867411430878">
<citation citation-type="book">
<collab>National Institute for Clinical Excellence</collab> (<year>2004</year>) <source>Depression: Management of Depression in Primary and Secondary Care</source>. <publisher-loc>NICE</publisher-loc>: <publisher-name>London</publisher-name>.</citation>
</ref>
<ref id="bibr49-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nutt</surname><given-names>DJ</given-names></name>
</person-group> (<year>2008</year>) <article-title>Relationship of neurotransmitters to the symptoms of major depressive disorder</article-title>. <source>Journal Clinical Psychiatry</source> <volume>69</volume>(<issue>E1</issue>): <fpage>4</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr50-0004867411430878">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Parker</surname><given-names>G</given-names></name>
<name><surname>Hadzi-Pavlovic</surname><given-names>D</given-names></name>
</person-group> (<year>1996</year>) <source>Melancholia: A Disorder of Movement and Mood</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Cambridge University Press</publisher-name>.</citation>
</ref>
<ref id="bibr51-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Parker</surname><given-names>G</given-names></name>
<name><surname>Hadzi-Pavlovic</surname><given-names>D</given-names></name>
<name><surname>Austin</surname><given-names>MP</given-names></name><etal/>
</person-group>. (<year>1995</year>) <article-title>Sub-typing depression. I: Is psychomotor disturbance necessary and sufficient to define melancholia?</article-title> <source>Psychological Medicine</source> <volume>25</volume>: <fpage>814</fpage>–<lpage>823</lpage>.</citation>
</ref>
<ref id="bibr52-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Parker</surname><given-names>G</given-names></name>
<name><surname>Roy</surname><given-names>K</given-names></name>
<name><surname>Wilhem</surname><given-names>K</given-names></name><etal/>
</person-group>. (<year>2001</year>) <article-title>Assessing the comparative effectiveness of antidepressant therapies: a prospective clinical practice study</article-title>. <source>Journal Clinical Psychiatry</source> <volume>62</volume>(<issue>2</issue>): <fpage>117</fpage>–<lpage>125</lpage>.</citation>
</ref>
<ref id="bibr53-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Post</surname><given-names>RM</given-names></name>
</person-group> (<year>1992</year>) <article-title>Transduction of psychosocial stress into the neurobiology of recurrent affective disorder</article-title>. <source>American Journal of Psychiatry</source> <volume>149</volume>: <fpage>999</fpage>–<lpage>1010</lpage>.</citation>
</ref>
<ref id="bibr54-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Preacher</surname><given-names>KJ</given-names></name>
<name><surname>Hayes</surname><given-names>AF</given-names></name>
</person-group> (<year>2008</year>) <article-title>Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models</article-title>. <source>Behavior Research Methods</source> <volume>40</volume>: <fpage>879</fpage>–<lpage>891</lpage>.</citation>
</ref>
<ref id="bibr55-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rattiner</surname><given-names>LM</given-names></name>
<name><surname>Davis</surname><given-names>M</given-names></name>
<name><surname>French</surname><given-names>CT</given-names></name><etal/>
</person-group>. (<year>2004</year>) <article-title>Brain-derived neurotrophic factor and tyrosine kinase receptor B involvement in amygdale-dependant fear conditioning</article-title>. <source>Journal of Neuroscience</source> <volume>24</volume>: <fpage>4796</fpage>–<lpage>4806</lpage>.</citation>
</ref>
<ref id="bibr56-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Risch</surname><given-names>N</given-names></name>
<name><surname>Herrell</surname><given-names>R</given-names></name>
<name><surname>Lehner</surname><given-names>T</given-names></name><etal/>
</person-group>. (<year>2009</year>) <article-title>Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta analysis</article-title>. <source>Journal of the American Medical Association</source> <volume>301</volume>(<issue>23</issue>): <fpage>2462</fpage>–<lpage>2471</lpage>.</citation>
</ref>
<ref id="bibr57-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rubino</surname><given-names>A</given-names></name>
<name><surname>Zanasi</surname><given-names>M</given-names></name>
<name><surname>Robone</surname><given-names>C</given-names></name><etal/>
</person-group>. (<year>2009</year>) <article-title>Personality differences between depressed melancholic and non-melancholic patients</article-title>. <source>Australian New Zealand Journal of Psychiatry</source> <volume>43</volume>: <fpage>145</fpage>–<lpage>148</lpage>.</citation>
</ref>
<ref id="bibr58-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rybakowski</surname><given-names>JK</given-names></name>
<name><surname>Borkowska</surname><given-names>A</given-names></name>
<name><surname>Czerski</surname><given-names>PM</given-names></name><etal/>
</person-group>. (<year>2003</year>) <article-title>Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients</article-title>. <source>Bipolar Disorder</source> <volume>5</volume>: <fpage>468</fpage>–<lpage>472</lpage>.</citation>
</ref>
<ref id="bibr59-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Santarelli</surname><given-names>L</given-names></name>
<name><surname>Saxe</surname><given-names>M</given-names></name>
<name><surname>Fross</surname><given-names>C</given-names></name><etal/>
</person-group>. (<year>2003</year>) <article-title>Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants</article-title>. <source>Science</source> <volume>301</volume>(<issue>5634</issue>): <fpage>805</fpage>–<lpage>809</lpage>.</citation>
</ref>
<ref id="bibr60-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sheehan</surname><given-names>DV</given-names></name>
<name><surname>Lecrubier</surname><given-names>Y</given-names></name>
<name><surname>Sheehan</surname><given-names>KH</given-names></name><etal/>
</person-group>. (<year>1998</year>) <article-title>Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10</article-title>. <source>Journal of Clinical Psychiatry</source> <volume>59</volume>(<issue>20</issue>): <fpage>34</fpage>–<lpage>57</lpage>.</citation>
</ref>
<ref id="bibr61-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shimizu</surname><given-names>E</given-names></name>
<name><surname>Hashimoto</surname><given-names>K</given-names></name>
<name><surname>Okamura</surname><given-names>N</given-names></name><etal/>
</person-group>. (<year>2003</year>) <article-title>Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants</article-title>. <source>Biological Psychiatry</source> <volume>54</volume>: <fpage>70</fpage>–<lpage>75</lpage>.</citation>
</ref>
<ref id="bibr62-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stein</surname><given-names>D</given-names></name>
</person-group> (<year>2008</year>) <article-title>Depression, anhedonia, and psychomotor symptoms: the role of dopaminergic neurocircuitry</article-title>. <source>CNS Spectrums</source> <volume>13</volume>(<issue>7</issue>): <fpage>561</fpage>–<lpage>565</lpage>.</citation>
</ref>
<ref id="bibr63-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stewart</surname><given-names>J</given-names></name>
<name><surname>McGrath</surname><given-names>P</given-names></name>
<name><surname>Quitkin</surname><given-names>F</given-names></name><etal/>
</person-group>. (<year>1989</year>) <article-title>Relevance of DMS-III depressive subtype and chronicity of antidepressant efficacy in atypical depression</article-title>. <source>Archives of General Psychiatry</source> <volume>46</volume>(<issue>12</issue>): <fpage>1080</fpage>–<lpage>1087</lpage>.</citation>
</ref>
<ref id="bibr64-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sullivan</surname><given-names>P</given-names></name>
<name><surname>Neale</surname><given-names>M</given-names></name>
<name><surname>Kendler</surname><given-names>K</given-names></name>
</person-group> (<year>2000</year>) <article-title>Genetic epidemiology of major depression: review and meta-analysis</article-title>. <source>American Journal of Psychiatry</source> <volume>157</volume>: <fpage>1552</fpage>–<lpage>1562</lpage>.</citation>
</ref>
<ref id="bibr65-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Urani</surname><given-names>A</given-names></name>
<name><surname>Chourbaji</surname><given-names>S</given-names></name>
<name><surname>Gass</surname><given-names>P</given-names></name>
</person-group> (<year>2005</year>) <article-title>Mutant mouse models of depression: candidate genes and current mouse lines</article-title>. <source>Neuroscience Biobehavioral Reviews</source> <volume>29</volume>(<issue>4-5</issue>): <fpage>805</fpage>–<lpage>828</lpage>.</citation>
</ref>
<ref id="bibr66-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wichers</surname><given-names>M</given-names></name>
<name><surname>Geshwind</surname><given-names>N</given-names></name>
<name><surname>Jacobs</surname><given-names>N</given-names></name><etal/>
</person-group>. (<year>2009</year>) <article-title>Transition from stress sensitivity to a depressive state: longitudinal twin study</article-title>. <source>British Journal of Psychiatry</source> <volume>195</volume>: <fpage>498</fpage>–<lpage>503</lpage>.</citation>
</ref>
<ref id="bibr67-0004867411430878">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wilhelm</surname><given-names>K</given-names></name>
<name><surname>Mitchell</surname><given-names>PB</given-names></name>
<name><surname>Niven</surname><given-names>H</given-names></name>
</person-group> (<year>2006</year>) <article-title>Life events, first depression onset and the serotonin transporter gene</article-title>. <source>British Journal of Psychiatry</source> <volume>188</volume>: <fpage>210</fpage>–<lpage>215</lpage>.</citation>
</ref>
<ref id="bibr68-0004867411430878">
<citation citation-type="web">
<collab>World Health Organisation</collab> (<year>2005</year>) <article-title>Revised global burden of disease (GBD) 2002 estimates</article-title>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/healthinfo/bodgbd2002revised/en/index.html">http://www.who.int/healthinfo/bodgbd2002revised/en/index.html</ext-link></comment>. (<access-date>accessed 20 August 2010</access-date>)</citation>
</ref>
</ref-list>
</back>
</article>